Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 1-800-239-2901

1215 South Walnut Ave.
Demopolis, AL 36732
334.289.2416 (fax)

powered by centersite dot net
Medical Disorders
Basic InformationLookupsLatest News
Time Spent in ICU Linked to Higher Odds for Suicide LaterBiden Sets New Goal of Vaccinating 70% of Americans by July 4Wildfires Are Changing the Seasonal Air Quality of the U.S. WestYou Got Your COVID Shot: What to Do With That Vaccine CardUrgent Care or the ER? Which Should You Choose?Poll Reveals Who's Most Vaccine-Hesitant in America and WhyHead Injury, Alzheimer's Appear to Affect Brain in Similar WaysLow Risk of Mom Passing COVID to NewbornCDC Decision on Johnson & Johnson Vaccine Pause Expected FridayAHA News: How to Make Sure Everyone Gets a Fair Shot at the COVID-19 Vaccine'Disrupted' Sleep Could Be Seriously Affecting Your HealthWildfire Smoke Can Trigger Eczema, Study FindsHormone Treatments May Raise Blood Pressure in Transgender PeopleCDC Panel Says It Needs More Time to Study J&J Vaccine Clotting CasesResearch Shows Links Between Gum Disease and Alzheimer'sNo Rise in Global Suicide Rate in First Months of PandemicNewborns Won't Get COVID Through Infected Mom's Breast Milk: StudyPandemic Has Put Many Clinical Trials on HoldStressed, Exhausted: Frontline Workers Faced Big Mental Strain in Pandemic'Heart-in-a-Box' Can Be Lifesaving, Matching Up Distant Donors With PatientsPublic Lost Trust in CDC During COVID Crisis: PollNearly 8 in 10 School, Child Care Staff Have Gotten at Least 1 Dose of COVID Vaccine: CDCStrain of COVID Care Has Many Health Professionals Looking for an ExitHow Willing Are Americans to Donate COVID Vaccines to Other Countries?Biden Administration Working on 'Vaccine Passport' InitiativeStates Race to Vaccinate Their ResidentsStudy Finds Growing Acceptance of COVID Vaccine by U.S. Health Care WorkersTalks With Doctors May Be Key to Vaccine Acceptance: StudyAs U.S. Vaccinations Rise, Are 'Vaccine Passports' for Americans Coming?'Race Gap' in U.S. Heart Health Has Changed Little in 20 Years: ReportPeople With Intellectual Disabilities at High Risk for Fatal COVID-19Driven by Anti-Vaxxers, Measles Outbreaks Cost Everyone MoneyAHA News: Dementia May Be a Risk Factor for Infection But Not Death From COVID-19Pandemic Stress Has Americans Gaining Weight, Drinking More: PollScams Await Many Americans Desperate to Get COVID VaccineEven 1 Concussion May Raise Your Odds for Dementia LaterGlobal Warming Could Make Survival in Tropics Impossible: StudyWildfire Smoke Is Especially Toxic to Lungs, Study ShowsPandemic Stress Has More Americans Grinding Their TeethCDC Issues New Guidelines for Vaccinated AmericansHow Moving the Homeless to Hotels During the Pandemic Helps EveryoneFormaldehyde in Hair Straighteners Prompts FDA WarningPandemic Is Hitting Hospitals Hard, Including Their Bottom LineMental Health 'Epidemic' Threatens Communities of Color Amid COVID-19Got a Vaccine-Skeptical Relative? Here's How to Talk to Them1 in 3 Americans Delayed, Skipped Medical Care During PandemicHealth Care After COVID: A New Focus on Infectious DiseasesSilent Killer: Watch Out for Carbon Monoxide Dangers This WinterMost Americans Unhappy With U.S. Vaccine Rollout: PollAHA News: Surviving COVID-19 Survivor's Guilt
Questions and AnswersVideosLinksBook Reviews
Related Topics

Men's Health
Women's Health

Hormone Treatments May Raise Blood Pressure in Transgender People

HealthDay News
by Cara Murez
Updated: Apr 19th 2021

new article illustration

MONDAY, April 19, 2021 (HealthDay News) -- Monitoring blood pressure is important for transgender people, according to new research, which found changes in systolic blood pressure after the start of gender-affirming hormone therapy.

Transgender men and transgender women have a higher burden of heart attack, stroke and related conditions, the study noted.

Gender-affirming hormone therapy isn't new. Doctors have prescribed the hormones for more than 25 years, but little is known about their impact on high blood pressure rates and how the effects change over time.

"There are many important gaps in our knowledge about the effects of hormone therapy for transgender people," said senior author Dr. Michael Irwig, director of transgender medicine at Beth Israel Deaconess Medical Center in Boston. The research was published April 19 in the journal Hypertension.

"This study examined the time course and magnitude of the effects of gender-affirming hormones on blood pressure," Irwig said in a journal news release.

He and his colleagues followed 470 patients who began gender-affirming hormone therapy from early 2007 to mid-2015. They described their work as the largest and longest observational study of its kind.

Participants were all at least 17 years old, with 247 who were transfeminine (assigned male at birth but identify as female) and 223 who were transmasculine (assigned female at birth but identify as male). About 27% self-identified as non-white, and 16% identified as Hispanic.

Researchers measured participants' blood pressure before hormone therapy began and for up to 57 months -- nearly five years.

Within two to four months of beginning hormone therapy, transgender women saw an average drop of 4.0 mm Hg in their systolic blood pressure. Transgender men saw an average increase of 2.6 mm Hg.

Systolic blood pressure, the top number in a blood pressure reading, measures the force your heart exerts on artery walls each time it beats.

The prevalence of stage 2 high blood pressure fell from 19% to 10% in the transfeminine group within two to four months of starting hormone therapy, the study found.

The use of testosterone in transgender men could lead to an increased risk for heart attack or stroke if they also have untreated high blood pressure, researchers said.

Some participants saw blood pressure rates trend in the opposite direction compared to the majority of people with the same gender identity. Researchers said that would require more study to understand.

Previous research has found that transgender men were almost five times as likely to report having a heart attack compared to cisgender women (those assigned female at birth and identify as female).

Transgender women, meanwhile were more than 2.5 times more likely to have reported a heart attack than cisgender women. They did not have a significant increase in heart attack incidence when compared with cisgender men.

A systematic review conducted in 2020 found most of the studies examining gender-affirming hormones and blood pressure had too few participants to detect statistically significant differences in blood pressure.

Researchers noted that the new study also had some limitations. Among them: Most patients were on the same formulation of intramuscular testosterone or oral estrogen, so the effects of other formulations need further study in a more diverse group.

A 2020 Scientific Statement from the American Heart Association said it is paramount to include LGBTQ health in clinical training and license requirements for health care professionals in order to better address heart health disparities.

More information

Johns Hopkins Medicine has more information on transgender health.

SOURCE: Hypertension, news release, April 19, 2021